navigating between endocrine therapy, chemotherapy, and cdk 4/6 inhibitors for high-risk hr /her2...
Published 3 weeks ago • No plays • Length 32:14Download video MP4
Download video MP3
Similar videos
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
0:36
endocrine therapy and cdk4/6 inhibitors in high-risk hr breast cancer
-
1:09:24
raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors
-
1:12
remaining questions on the use of frontline cdk4/6 inhibitors endocrine therapy
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
33:11
recent updates in hr-positive/her2-negative early breast cancer: a deep dive into understanding t...
-
5:56
cdk 4/6 inhibitors for older women with hr-positive breast cancer
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer
-
58:22
adjuvant cdk4 and 6 inhibition to prevent recurrences in high-risk hr /her2- early breast cancer
-
6:05
cdk4/6 inhibitors & endocrine therapy: selecting a regimen
-
6:46
cdk4/6 inhibitors & endocrine therapy: treatment resistance
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
0:59
your preference for cdk4/6 inhibitor for metastatic hr breast cancer?
-
3:35
the benefits of adjuvant cdk4/6 and parp inhibition in breast cancer
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
3:56
hr breast cancer: risk-stratifying to cdk4/6 inhibitors